海外の感染症の最新の流行状況を情報をお知らせいたします。
※出典が海外のため原文のまま掲載しています。最新の記事はこちら
2024年2月5日時点の情報
Circulating vaccine-derived poliovirus type 2 (cVDPV2)|11 January 2024|Indonesia
The genetic sequencing of isolates at the BioFarma National Polio Laboratory indicates cVDPV2 with 36 nucleotide changes, genetically linked to a case in West Java province, that was reported to WHO in March 2023.
Epidemiological Alert – Oropouche in the Region of the Americas – 2 February 2024|2 Feb 2024|Pan American Health Organization
In recent months, there has been an increase in the detection of cases of Oropouche fever in certain areas of the Region of the Americas. In addition, there is a heightened prevalence of dengue circulation reported in several countries in the region. In response to this, the Pan American Health Organization / World Health Organization (PAHO/WHO) shares with Member States recommendations for the differential diagnosis of the Oropouche virus and recommends strengthening vector control and personal protection measures for the population most at risk.
Epidemiological Alert – Measles in the Region of the Americas – 29 January 2024|29 Jan 2024|Pan American Health Organization
Given the challenges related to the persistence of low coverage of the first and second doses of the vaccine against measles, rubella, and mumps (MMR1 and MMR2), the increase in measles cases globally, and the occurrence of imported cases in countries in the Region of the Americas, the Pan American Health Organization / World Health Organization (PAHO/WHO) urges Member States to continue with activities to increase and maintain adequate vaccination coverage against measles, rubella, and mumps and reiterates that vaccination, epidemiological surveillance, and preparation of rapid response to measles and rubella outbreaks constitute the three major strategies to annually monitor and reverify the interruption of endemic transmission of these viruses.
Cameroon kicks off malaria vaccine rollout|22 January 2024|African Region
Yaoundé – Cameroon today launched the RTS,S malaria vaccine into its routine national immunization services, becoming the first country to do so outside the malaria vaccine pilot programme that was carried out in Ghana, Kenya and Malawi. The introduction comes as efforts gather pace to scale up vaccination against the disease in high risk areas in Africa.
WHO Africa, Bill and Melinda Gates Foundation pursue collaboration to leverage data …|12 January 2024|African Region
Brazzaville – The World Health Organization (WHO) Regional Office for Africa and the Bill and Melinda Gates Foundation (BMGF) have committed to strengthening collaboration towards the use of data analytics in the fight against diseases in the African region. The commitment was made during a technical visit to the WHO Africa office in Brazzaville, Congo by a delegation from BMGF led by Jennifer Gardy, Deputy Director, Surveillance, Data, and Epidemiology from 8 to 10 January 2024.
WHO Certifies Cabo Verde as Malaria-Free, Marking a Historic Milestone in the Fight …|12 January 2024|African Region
The World Health Organization (WHO) has certified Cabo Verde as a malaria-free country, marking a significant achievement in global health. With this announcement, Cabo Verde joins the ranks of 43 countries and 1 territory that WHO has awarded this certification.
Stronger action urged as WHO fourth Global school on refugee and migrant health conc…|30 November 2023|African Region
Dakar – The fourth WHO Global School on Refugee and Migrant Health concluded in Dakar, Senegal with renewed optimism to address the crucial social factors that significantly impact the health of refugees and migrants worldwide.